2-Methyl-1-(2-(5-methyl-2-((4-morpholinophenyl)amino)pyrimidin-4-yl)-6,7-dihydrofuro[3,2-c]pyridin-5(4H)-yl)propan-1-one

ID: ALA4524537

PubChem CID: 72202825

Max Phase: Preclinical

Molecular Formula: C26H31N5O3

Molecular Weight: 461.57

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1-c1cc2c(o1)CCN(C(=O)C(C)C)C2

Standard InChI:  InChI=1S/C26H31N5O3/c1-17(2)25(32)31-9-8-22-19(16-31)14-23(34-22)24-18(3)15-27-26(29-24)28-20-4-6-21(7-5-20)30-10-12-33-13-11-30/h4-7,14-15,17H,8-13,16H2,1-3H3,(H,27,28,29)

Standard InChI Key:  PVKVZMYRWLFHQT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   34.6770  -11.4613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6770  -12.2826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3864  -12.6871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3864  -11.0445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0958  -11.4613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0957  -12.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8737  -12.5306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3562  -11.8682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8738  -11.2058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.1745  -11.8671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5825  -12.5806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4030  -12.5809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8166  -11.8686    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.3995  -11.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5803  -11.1575    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.8097  -10.4411    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.6310  -10.4382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0378  -11.1518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8584  -11.1493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2694  -10.4355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8498   -9.7269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0306   -9.7329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1732  -13.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0873  -10.4310    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.4981  -11.1426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.3159  -11.1406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7290  -10.4286    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.3140   -9.7211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4901   -9.7214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9699  -12.6923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2574  -12.2847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9710  -13.5136    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.2562  -11.4634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5462  -12.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 10  1  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 11 23  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 20 24  1  0
  2 30  1  0
 30 31  1  0
 30 32  2  0
 31 33  1  0
 31 34  1  0
M  END

Associated Targets(Human)

JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 461.57Molecular Weight (Monoisotopic): 461.2427AlogP: 4.17#Rotatable Bonds: 5
Polar Surface Area: 83.73Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.30CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.61Np Likeness Score: -1.41

References

1. Wang Y, Huang W, Xin M, Chen P, Gui L, Zhao X, Zhu X, Luo H, Cong X, Wang J, Liu F..  (2019)  Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors.,  27  (12): [PMID:30926315] [10.1016/j.bmc.2019.03.048]

Source